News & Events

• Genetic Analysis and Servatus enter Strategic Collaboration Agreement to develop new microbiome diagnostic and therapeutic solutions
  Published on 2022-06-22
• Vedanta Biosciences to Participate in the JMP Securities Life Sciences Conference
  Published on 2022-06-08
• Microba and Ginkgo commence therapeutics program
  Published on 2022-06-07
• Seres Therapeutics Announces Confirmatory Results from Investigational Microbiome Therapeutic SER-109 ECOSPOR IV Open-Label Study in Recurrent C. Difficile Infection
  Published on 2022-06-07
• Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
  Published on 2022-06-01
• Microba appoints CRO for IBD Clinical Trial
  Published on 2022-05-26
• Microba signs partnership with nib-backed Midnight Health
  Published on 2022-05-25
• Microbiome and Bile Acid Restoration was Consistent Across Three Clinical Trials of Rbx2660 for Recurrent Clostridioides Difficile Infection: A Combined Analysis
  Published on 2022-05-24
• Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
  Published on 2022-05-24
• Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting
  Published on 2022-05-22
• Genetic Analysis AS: Mandatory notification of trade – Primary Insider
  Published on 2022-05-20
• Genetic Analysis AS and Omnigene Medical Technologies Ltd. enter a distribution agreement to launch GA-map® in the United Arabic Emirates (UAE) market
  Published on 2022-05-19
• Interim report January – March 2022
  Published on 2022-05-13
• Seres Therapeutics to Present Data on Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting
  Published on 2022-05-10
• Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates
  Published on 2022-05-04